Clinical Trial Update: Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing adjunctive therapy with reboxetine and citalopram to second-generation antipsychotics for negative symptoms in schizophrenia; c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Citalopram (Citalopram hydrobromide)
• Reboxetine (Reboxetine)

Snippet

Sponsor: Fundació Sant Joan de Déu | Conditions: Schizophrenia | Phase 4 | Status: UNKNOWN